The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma
Clinical trial NCT06522555 · RECRUITING
Trial details
- NCT number
- NCT06522555
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-29
- Primary completion
- 2028-08-10
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.